Viral Vector Manufacturing Market Size, Share, Trends and Revenue Forecast, 2030

Global Viral Vector Manufacturing Market Research Report: Forecast (2024-2030)

Global Viral Vector Manufacturing Market Report- By Vector Type (Adenoviral Vector, Adeno-Associated Viral Vector, Lentiviral Vector, Herpes Simplex Viral-Vector, Retroviral Vector, Others (CMV, HSV-1... ... , Others (CMV, HSV-1, Vaccina, etc.)), By Application (Gene Therapy, Cell Therapy, Vaccines, (Non-Replicating Viral Vector Vaccines, Replicating Viral Vector Vaccines)), ndication (Genetic Disorders, (Hemophilia, Sickle Cell Disease, Duchenne muscular dystrophy, Beta-Thalassemia, Spinal Muscular Atrophy (SMA), Others (inherited retinal disorder, cerebral adrenoleukodystrophy (CALD, severe combined immunodeficiency due to adenosine deaminase deficiency)), Cancer, (Bladder Cancer, Blood Cancer, Head & Neck Cancer), Infectious Diseases, (COVID-19, Ebola Virus, Malaria), By Scale of Operation (Pre-Clinical, Clinical, Commercial), By End User (Biotech Companies, Pharmaceutical Companies, Research Organizations), and Others Read more

Healthcare
May 2024
Pages 201
Report Format: PDF, Excel, PPT

Market Definition

Viral vectors are specialized tools used in genetic engineering and gene therapy. They are modified viruses designed to deliver genetic material, such as therapeutic genes or DNA constructs, into target cells. By leveraging the natural ability of viruses to infect cells and introduce their genetic material, viral vectors enable scientists to manipulate gene expression, correct genetic defects, or trigger desired cellular responses for therapeutic purposes.

Market Insights & Analysis: Global Viral Vector Manufacturing Market (2024-30):

The Global Viral Vector Manufacturing Market is estimated to grow at a CAGR of around 19.22% during the forecast period, i.e., 2024-30. This growth trajectory is primarily attributed to two key factors, i.e., the escalating incidence of epidemics and pandemics, which has expedited vaccine development efforts, and the mounting investments in gene therapy initiatives. Hence, as investments in vaccine and gene therapy development improved, the demand for viral vector manufacturing services also escalated, as they have been an important part of research procedures.

Further, the prevalence of various cancer types, including blood & bladder cancer, has surged worldwide. Data from the Global Cancer Observatory 2024 reveals a notable increase in new cases of Non-Hodgkin lymphoma globally, from 44,352 cases in 2020 to 553 thousand cases in 2022. Similarly, there has been a rise in leukemia cases from 474 thousand in 2020 to 487 thousand in 2022 worldwide. Bladder cancer cases have also surged, with the number of new cases reaching 614 thousand in 2022, compared to 573 thousand in 2020.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	19.22%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Rest of South America
	Middle East & Africa: UAE, Saudi Arabia, Rest of MEA
Key Companies Profiled	Oxford Biomedica PLC, Charles River Laboratories, FUJIFILM Corporation, Lonza, Merck KgaA, Catalent, Inc., AGC Biologics, Thermo Fisher Scientific Inc., Vector BioMed, Biovian Oy, ReiThera srl, Curia Global, Inc., Aurigene Pharmaceutical Services Ltd., Revvity, etc.
Unit Denominations	USD Million/Billion

Moreover, the escalating patient count for blood and bladder cancer globally has fueled demand for better cancer treatments. Hence, owing to this, there has been a substantial inclination of healthcare professionals toward the promising potential of cancer gene therapy and cell therapy treatments to enhance the efficacy of current therapeutic regimens. Consequently, with the growing demand for gene and cell therapy, there would be a heightened demand for viral vectors, an essential component in cancer gene therapy and cell therapy, further driving the Global Viral Vector Manufacturing Market during 2024-30.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Viral Vector Manufacturing Market Trends & Developments
Global Viral Vector Manufacturing Market Dynamics
1. Drivers
2. Challenges
Global Viral Vector Manufacturing Market Hotspot & Opportunities
Global Viral Vector Manufacturing Market Regulations & Policy
Global Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Vector Type
    1. Adenoviral Vector- Market Size & Forecast 2019-2030, USD Million
    2. Adeno-Associated Viral Vector- Market Size & Forecast 2019-2030, USD Million
    3. Lentiviral Vector- Market Size & Forecast 2019-2030, USD Million
    4. Herpes Simplex Viral-Vector- Market Size & Forecast 2019-2030, USD Million
    5. Retroviral Vector- Market Size & Forecast 2019-2030, USD Million
    6. Others (CMV, HSV-1, Vaccina, etc.)- Market Size & Forecast 2019-2030, USD Million
  2. By Application
    1. Gene Therapy- Market Size & Forecast 2019-2030, USD Million
    2. Cell Therapy- Market Size & Forecast 2019-2030, USD Million
    3. Vaccines- Market Size & Forecast 2019-2030, USD Million
      1. Non-Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million
      2. Replicating Viral Vector Vaccines- Market Size & Forecast 2019-2030, USD Million
  3. By Indication
    1. Genetic Disorders- Market Size & Forecast 2019-2030, USD Million
      1. Hemophilia- Market Size & Forecast 2019-2030, USD Million
      2. Sickle Cell Disease- Market Size & Forecast 2019-2030, USD Million
      3. Duchenne muscular dystrophy- Market Size & Forecast 2019-2030, USD Million
      4. Beta-Thalassemia- Market Size & Forecast 2019-2030, USD Million
      5. Spinal Muscular Atrophy (SMA)- Market Size & Forecast 2019-2030, USD Million
      6. Others (inherited retinal disorder, cerebral adrenoleukodystrophy (CALD, severe combined immunodeficiency due to adenosine deaminase deficiency)- Market Size & Forecast 2019-2030, USD Million
    2. Cancer- Market Size & Forecast 2019-2030, USD Million
      1. Bladder Cancer- Market Size & Forecast 2019-2030, USD Million
      2. Blood Cancer- Market Size & Forecast 2019-2030, USD Million
      3. Head & Neck Cancer- Market Size & Forecast 2019-2030, USD Million
    3. Infectious Diseases- Market Size & Forecast 2019-2030, USD Million
      1. COVID-19- Market Size & Forecast 2019-2030, USD Million
      2. Ebola Virus- Market Size & Forecast 2019-2030, USD Million
      3. Malaria- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation
    1. Pre-Clinical- Market Size & Forecast 2019-2030, USD Million
    2. Clinical- Market Size & Forecast 2019-2030, USD Million
    3. Commercial- Market Size & Forecast 2019-2030, USD Million
  5. By End User
    1. Biotech Companies- Market Size & Forecast 2019-2030, USD Million
    2. Pharmaceutical Companies- Market Size & Forecast 2019-2030, USD Million
    3. Research Organizations- Market Size & Forecast 2019-2030, USD Million
  6. By Region
    1. North America
    2. South America
    3. Europe
    4. The Middle East & Africa
    5. Asia-Pacific
  7. By Competition
    1. Competition Characteristics
    2. Market Share of Companies
North America Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
  2. By Application- Market Size & Forecast 2019-2030, USD Million
  3. By Indication- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation- Market Size & Forecast 2019-2030, USD Million
  5. By End User- Market Size & Forecast 2019-2030, USD Million
  6. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
4. Canada Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
5. Mexico Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
South America Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
  2. By Application- Market Size & Forecast 2019-2030, USD Million
  3. By Indication- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation- Market Size & Forecast 2019-2030, USD Million
  5. By End User- Market Size & Forecast 2019-2030, USD Million
  6. By Country
    1. Brazil
    2. Rest of South America
3. Brazil Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
Europe Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Vector Type Market Size & Forecast 2019-2030, USD Million
  2. By Application- Market Size & Forecast 2019-2030, USD Million
  3. By Indication- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation- Market Size & Forecast 2019-2030, USD Million
  5. By End User- Market Size & Forecast 2019-2030, USD Million
  6. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
4. The UK Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
5. France Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
6. Spain Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
7. Italy Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Connectivity- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
The Middle East & Africa Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
  2. By Application- Market Size & Forecast 2019-2030, USD Million
  3. By Indication- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation- Market Size & Forecast 2019-2030, USD Million
  5. By End User- Market Size & Forecast 2019-2030, USD Million
  6. By Country
    1. Saudi Arabia
    2. The UAE
    3. Rest of the Middle East & Africa
3. Saudi Arabia Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
4. The UAE Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
Asia-Pacific Viral Vector Manufacturing Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Vector Type - Market Size & Forecast 2019-2030, USD Million
  2. By Application- Market Size & Forecast 2019-2030, USD Million
  3. By Indication- Market Size & Forecast 2019-2030, USD Million
  4. By Scale of Operation- Market Size & Forecast 2019-2030, USD Million
  5. By End User- Market Size & Forecast 2019-2030, USD Million
  6. By Country
    1. China
    2. Japan
    3. Australia
    4. South Korea
    5. India
    6. Rest of Asia-Pacific
3. China Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
4. Japan Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
5. Australia Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
6. South Korea Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
7. India Viral Vector Manufacturing Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Vector Type- Market Size & Forecast 2019-2030, USD Million
    2. By End User- Market Size & Forecast 2019-2030, USD Million
Global Viral Vector Manufacturing Market Key Strategic Imperatives for Growth & Success
Competitive Outlook
1. Company Profiles
  1. Oxford Biomedica PLC
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. Charles River Laboratories
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. FUJIFILM Corporation
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. Lonza
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Merck KGaA
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Catalent, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. AGC Biologics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Thermo Fisher Scientific Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Vector BioMed
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Biovian Oy
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. ReiThera srl
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Curia Global, Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Aurigene Pharmaceutical Services Ltd.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Revvity Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. SK Pharmteco Inc.
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  16. Others
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

Full Name*:

Company Name*:

Business Email*:

Country Name*:

Contact Number*:

Message:

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Inquire Before Buying